CONMED Corp — Director's Dealing 2023

May 2, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2023-04-28

Reporting Person: Jonas Daniel S (Special Counsel & Corp Secy)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-04-28	Common Stock	G	626	—	Disposed	13462	Direct
2023-04-28	Common Stock	M	10000	$97.69	Acquired	23462	Direct
2023-04-28	Common Stock	S	5500	$125.57	Disposed	17962	Direct
2023-04-28	Common Stock	S	4300	$126.72	Disposed	13662	Direct
2023-04-28	Common Stock	S	200	$127.56	Disposed	13462	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-04-28	Options To Purchase Common Stock	$97.69	M	10000	Disposed	2030-03-02	Common Stock (10000)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.30 to $126.25. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.36 to $127.26. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder,

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.42 to $127.70. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F4: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period